Literature DB >> 28452828

Telephone Encounters Predict Future High Financial Expenditures in Inflammatory Bowel Disease Patients: A 3-Year Prospective Observational Study.

Benjamin Click1, Alyce M Anderson, Claudia Ramos Rivers, Ioannis E Koutroubakis, Jana G Hashash, Michael A Dunn, Marc Schwartz, Jason Swoger, Arthur Barrie, Eva Szigethy, Miguel Regueiro, Robert E Schoen, David G Binion.   

Abstract

BACKGROUND: Telephone activity is essential in management of complex chronic diseases including inflammatory bowel disease (IBD). Telephone encounters logged in the electronic medical record have recently been proposed as a surrogate marker of disease activity and impending health care utilization; however, the association between telephone calls and financial expenditures has not been evaluated. STUDY: We performed a 3-year prospective observational study of telephone encounters logged at a tertiary referral IBD center. We analyzed patient demographics, disease characteristics, comorbidities, clinical activity, and health care financial charges by telephone encounter frequency.
RESULTS: Eight hundred one patients met inclusion criteria (52.3% female; mean age, 44.1 y), accounted for 12,669 telephone encounters, and accrued $70,513,449 in charges over 3 years. High telephone encounter frequency was associated with female gender (P=0.003), anxiety/depression (P<0.001), and prior IBD surgery (P<0.001). High telephone encounter categories had significantly more hospitalizations (P<0.001), IBD surgery (P<0.001), worse quality of life (P<0.001), more corticosteroid (P<0.001), biological (P<0.001), and opiate prescriptions (P<0.001). High telephone encounter frequency patients amassed higher total available charges in each year (P<0.001) and over the 3 years (P<0.001). Telephone encounters in 2009 (P=0.02) and 2010 (P<0.001) were significantly associated with financial charges the following year after controlling for demographic, utilization, and medication covariates.
CONCLUSIONS: Increased telephone encounters are associated with significantly higher health care utilization and financial expenditures. Increased call frequency is predictive of future health care spending. Telephone encounters are a useful tool to identify patients at risk of clinical deterioration and large financial expense.

Entities:  

Mesh:

Year:  2018        PMID: 28452828      PMCID: PMC5659979          DOI: 10.1097/MCG.0000000000000801

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  38 in total

1.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

2.  Bone mineral density in patients with inflammatory bowel disease from north-eastern Romania.

Authors:  Gabriela Dumitrescu; Cătălina Mihai; Mihaela Dranga; Cristina Cijevschi Prelipcean
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  2013 Jan-Mar

3.  Clinical predictors of frequent patient telephone calls in Parkinson's disease.

Authors:  Anli A Liu; Christine E Boxhorn; Michael A Klufas; Paul J Christos; Jeffrey T Thorne; Angela Y Shih; Nadejda M Tsankova; Benjamin J Dorfman; Claire Henchcliffe; Panida Piboolnurak; Melissa J Nirenberg
Journal:  Parkinsonism Relat Disord       Date:  2010-11-27       Impact factor: 4.891

4.  Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.

Authors:  S Ardizzone; S Bollani; P Bettica; M Bevilacqua; P Molteni; G Bianchi Porro
Journal:  J Intern Med       Date:  2000-01       Impact factor: 8.989

5.  Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life.

Authors:  Alejandra H Faust; Leslie F Halpern; Sharon Danoff-Burg; Raymond K Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

6.  Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.

Authors:  Michael D Kappelman; Sheryl L Rifas-Shiman; Carol Q Porter; Daniel A Ollendorf; Robert S Sandler; Joseph A Galanko; Jonathan A Finkelstein
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

Review 7.  Distance management of inflammatory bowel disease: systematic review and meta-analysis.

Authors:  Vivian W Huang; Krista M Reich; Richard N Fedorak
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 8.  Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Laura M Mackner; Rachel Neff Greenley; Eva Szigethy; Michele Herzer; Kate Deer; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-04       Impact factor: 2.839

9.  Mental health profile of callers to a telephone counselling service.

Authors:  Nicole Burgess; Helen Christensen; Liana S Leach; Louise Farrer; Kathleen M Griffiths
Journal:  J Telemed Telecare       Date:  2008       Impact factor: 6.184

10.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.